These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21618940)

  • 21. [Indications of anakinra].
    Chauffier K; London J; Beaudouin C; Fautrel B
    Presse Med; 2009 May; 38(5):799-807. PubMed ID: 19278814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acute gouty arthritis in complex hospitalized patients with anakinra.
    Ghosh P; Cho M; Rawat G; Simkin PA; Gardner GC
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1381-4. PubMed ID: 23650178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term effects of intra-articular botulinum toxin A for refractory joint pain.
    Mahowald ML; Singh JA; Dykstra D
    Neurotox Res; 2006 Apr; 9(2-3):179-88. PubMed ID: 16785116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
    Furst DE
    Clin Ther; 2004 Dec; 26(12):1960-75. PubMed ID: 15823761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-Articular Knee Injections Before Total Knee Arthroplasty: Outcomes and Complication Rates.
    Kokubun BA; Manista GC; Courtney PM; Kearns SM; Levine BR
    J Arthroplasty; 2017 Jun; 32(6):1798-1802. PubMed ID: 28238583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of interleukin-1β in arthritic pain: main involvement in thermal, but not mechanical, hyperalgesia in rat antigen-induced arthritis.
    Ebbinghaus M; Uhlig B; Richter F; von Banchet GS; Gajda M; Bräuer R; Schaible HG
    Arthritis Rheum; 2012 Dec; 64(12):3897-907. PubMed ID: 22933159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.
    Sibley CH; Plass N; Snow J; Wiggs EA; Brewer CC; King KA; Zalewski C; Kim HJ; Bishop R; Hill S; Paul SM; Kicker P; Phillips Z; Dolan JG; Widemann B; Jayaprakash N; Pucino F; Stone DL; Chapelle D; Snyder C; Butman JA; Wesley R; Goldbach-Mansky R
    Arthritis Rheum; 2012 Jul; 64(7):2375-86. PubMed ID: 22294344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
    Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
    Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra.
    Ikonomidis I; Tzortzis S; Lekakis J; Paraskevaidis I; Dasou P; Parissis J; Nikolaou M; Markantonis SL; Katsimbri P; Skarantavos G; Andreadou I; Anastasiou-Nana M
    Thromb Haemost; 2011 Nov; 106(5):959-67. PubMed ID: 21947196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A potential mode of action for Anakinra in patients with arthrofibrosis following total knee arthroplasty.
    Dixon D; Coates J; del Carpio Pons A; Horabin J; Walker A; Abdul N; Kalson NS; Brewster NT; Weir DJ; Deehan DJ; Mann DA; Borthwick LA
    Sci Rep; 2015 Nov; 5():16466. PubMed ID: 26553966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
    Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
    Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis].
    Botsios C; Sfriso P; Furlan A; Ostuni P; Biscaro M; Fiocco U; Todesco S; Punzi L
    Reumatismo; 2007; 59(1):32-7. PubMed ID: 17435840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of osteoarthritis with anakinra.
    Iqbal I; Fleischmann R
    Curr Rheumatol Rep; 2007 Apr; 9(1):31-5. PubMed ID: 17437664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
    Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial.
    Auw Yang KG; Raijmakers NJ; van Arkel ER; Caron JJ; Rijk PC; Willems WJ; Zijl JA; Verbout AJ; Dhert WJ; Saris DB
    Osteoarthritis Cartilage; 2008 Apr; 16(4):498-505. PubMed ID: 17825587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
    Clark W; Jobanputra P; Barton P; Burls A
    Health Technol Assess; 2004 May; 8(18):iii-iv, ix-x, 1-105. PubMed ID: 15130461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-articular injection with triamcinolone hexacetonide in patients with rheumatoid arthritis: prospective assessment of goniometry and joint inflammation parameters.
    Furtado RNV; Machado FS; Luz KRD; Santos MFD; Konai MS; Lopes RV; Natour J
    Rev Bras Reumatol Engl Ed; 2017; 57(2):115-121. PubMed ID: 28343615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development of postoperative knee chondrolysis after intra-articular pain pump infusion of an anesthetic medication: a series of twenty-one cases.
    Noyes FR; Fleckenstein CM; Barber-Westin SD
    J Bone Joint Surg Am; 2012 Aug; 94(16):1448-57. PubMed ID: 22786851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 cases.
    Thomas M; Forien M; Palazzo E; Dieudé P; Ottaviani S
    Clin Rheumatol; 2019 Feb; 38(2):425-430. PubMed ID: 30145636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-articular ropivacaine injection does not alleviate pain after day-case knee arthroscopy performed under spinal anaesthesia.
    Santanen U; Rautoma P; Luurila H; Erkola O
    Ann Chir Gynaecol; 2001; 90(1):47-50. PubMed ID: 11336370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.